Soleno Therapeutics (SLNO) Short Interest Ratio & Short Volume $79.15 -0.65 (-0.81%) Closing price 04:00 PM EasternExtended Trading$79.18 +0.03 (+0.04%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Soleno Therapeutics Short Interest DataSoleno Therapeutics (SLNO) has a short interest of 3.99 million shares, representing 9.57% of the float (the number of shares available for trading by the public). This marks a -3.86% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 763,274 shares to cover all short positions.Current Short Interest3,990,000 sharesPrevious Short Interest4,150,000 sharesChange Vs. Previous Month-3.86%Dollar Volume Sold Short$292.23 millionShort Interest Ratio3.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares50,394,000 sharesFloat Size41,690,000 sharesShort Percent of Float9.57%Today's Trading Volume806,045 sharesAverage Trading Volume763,274 sharesToday's Volume Vs. Average106% Short Selling Soleno Therapeutics? Sign up to receive the latest short interest report for Soleno Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLNO Short Interest Over TimeSLNO Days to Cover Over TimeSLNO Percentage of Float Shorted Over Time Soleno Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20253,990,000 shares $292.23 million -3.9%9.6%3 $73.24 5/15/20254,150,000 shares $311.54 million -0.2%10.0%3.2 $75.07 4/30/20254,160,000 shares $311.42 million -17.0%10.4%3.3 $74.86 4/15/20255,010,000 shares $351.95 million +7.5%12.7%4.2 $70.25 3/31/20254,660,000 shares $332.96 million -6.6%13.0%4.3 $71.45 3/15/20254,990,000 shares $246.21 million +3.7%14.9%9 $49.34 2/28/20254,810,000 shares $234.82 million +6.0%14.4%9.2 $48.82 2/15/20254,540,000 shares $223.23 million +4.4%14.4%8.2 $49.17 1/31/20254,350,000 shares $218.50 million -8.0%13.4%7.6 $50.23 1/15/20254,730,000 shares $229.74 million +3.1%14.5%8 $48.57 Get the Latest News and Ratings for SLNO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20244,590,000 shares $206.32 million +3.6%14.3%6.6 $44.95 12/15/20244,430,000 shares $206.93 million -2.9%13.8%6.5 $46.71 11/30/20244,560,000 shares $240.36 million -3.8%14.2%6.9 $52.71 11/15/20244,740,000 shares $245.53 million -23.2%14.8%7.2 $51.80 10/31/20246,170,000 shares $339.72 million +8.1%20.1%9.8 $55.06 10/15/20245,710,000 shares $309.20 million +15.1%20.6%9.5 $54.15 9/30/20244,960,000 shares $250.43 million +6.4%19.1%9.1 $50.49 9/15/20244,660,000 shares $246.23 million +3.8%18.0%8.9 $52.84 8/31/20244,490,000 shares $219.79 million +13.1%18.2%8.6 $48.95 8/15/20243,970,000 shares $200.33 million +0.3%16.9%8.4 $50.46 7/31/20243,960,000 shares $190.99 million -0.8%17.5%8.7 $48.23 7/15/20243,990,000 shares $200.34 million +13.7%18.7%7.7 $50.21 6/30/20243,510,000 shares $143.21 million +4.5%15.6%6.9 $40.80 6/15/20243,360,000 shares $142.50 million -1.2%15.0%7.7 $42.41 5/31/20243,400,000 shares $143.07 million +6.9%16.0%8.3 $42.08 5/15/20243,180,000 shares $143.77 million -6.7%15.0%7.4 $45.21 4/30/20243,410,000 shares $152.29 million +10.0%16.9%8.6 $44.66 4/15/20243,100,000 shares $119.41 million +12.3%15.7%10.2 $38.52 3/31/20242,760,000 shares $118.13 million +20.0%14.6%9 $42.80 3/15/20242,300,000 shares $99.96 million +36.9%12.2%7.8 $43.46 2/29/20241,680,000 shares $81.18 million +11.3%9.5%4.9 $48.32 2/15/20241,510,000 shares $70.17 million -0.7%8.5%4.8 $46.47 1/31/20241,520,000 shares $70.45 million +8.6%8.4%4.7 $46.35 1/15/20241,400,000 shares $58.51 million +4.5%7.8%4.4 $41.79 12/31/20231,340,000 shares $53.94 million +77.0%7.3%4 $40.25 12/15/2023756,900 shares $28.68 million +10.8%4.1%0.6 $37.89 11/30/2023683,300 shares $20.34 million +17.9%3.9%0.6 $29.76 11/15/2023579,500 shares $13.62 million -15.0%3.3%0.5 $23.51 10/31/2023682,000 shares $16.27 million +4.8%4.2%0.6 $23.85 10/15/2023650,500 shares $15.77 million -58.6%4.0%0.6 $24.25Banks aren’t ready for this altcoin—are you? (Ad)Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity is closing soon… Act now and get ready for what could be the most lucrative investment of your life.Click Here to Get #1 Crypto Now 9/30/20231,570,000 shares $46.33 million +683.0%15.7%1.5 $29.51 9/15/2023200,500 shares $982.45 thousand +151.9%2.5%0.3 $4.90 8/31/202379,600 shares $389.24 thousand -3.2%1.0%1.4 $4.89 8/15/202382,200 shares $371.54 thousand +13.7%1.1%1.3 $4.52 7/31/202372,300 shares $368.73 thousand -12.8%1.2%0.7 $5.10 7/15/202382,900 shares $446.00 thousand +14.0%1.3%0.8 $5.38 6/30/202372,700 shares $311.88 thousand -19.1%1.2%0.7 $4.29 6/15/202389,900 shares $449.50 thousand -9.1%1.4%0.8 $5.00 5/31/202398,900 shares $521.20 thousand +39.3%1.6%1 $5.27 5/15/202371,000 shares $298.56 thousand +14.7%1.3%0.8 $4.21 4/30/202361,900 shares $208.60 thousand -42.8%1.4%1.3 $3.37 4/15/2023108,200 shares $349.49 thousand +27.6%1.9%1.7 $3.23 3/31/202384,800 shares $181.47 thousand -7.3%1.5%1.1 $2.14 3/15/202391,500 shares $187.58 thousand -16.1%1.6%0.3 $2.05 2/28/2023109,000 shares $221.27 thousand -1.0%1.9%0.1 $2.03 2/15/2023110,100 shares $214.70 thousand -40.3%2.5%0.1 $1.95 1/31/2023184,300 shares $536.31 thousand -30.6%4.1%0.1 $2.91 1/15/2023265,400 shares $631.65 thousand -55.1%6.0%0.1 $2.38 12/30/2022590,900 shares $1.17 million +498.1%13.3%0.3 $1.98 12/15/202298,800 shares $88.13 thousand +14.8%2.2%0.1 $0.89 11/30/202286,100 shares $92.99 thousand +65.3%1.9%1.3 $1.08 11/15/202252,100 shares $56.79 thousand +10.2%1.2%0.5 $1.09 10/31/202247,300 shares $46.83 thousand +65.4%1.1%0.5 $0.99 10/15/202228,600 shares $38.04 thousand -53.0%0.7%0.3 $1.33 9/30/202260,900 shares $101.70 thousand +13.8%1.4%0.5 $1.67 9/15/202253,500 shares $115.03 thousand +21.6%1.3%0.4 $2.15 8/31/202244,000 shares $96.80 thousand -94.5%1.0%0.3 $2.20 8/15/2022799,600 shares $153.92 thousand -31.7%1.3%0.4 $0.19 7/31/20221,170,000 shares $200.07 thousand +65.0%N/A0.6 $0.17 7/15/2022709,300 shares $130.94 thousand -14.3%N/A0.4 $0.18 6/30/2022827,600 shares $153.11 thousand +140.2%N/A0.6 $0.19 6/15/2022344,500 shares $56.50 thousand +12.3%N/A0.2 $0.16 5/31/2022306,800 shares $49.49 thousand +37.2%N/A0.3 $0.16 5/15/2022223,700 shares $37.76 thousand -21.1%N/A0.3 $0.17 4/30/2022283,400 shares $56.68 thousand -25.5%0.4%0.4 $0.20 4/15/2022380,300 shares $82.75 thousand -36.8%0.5%0.6 $0.22 3/31/2022601,400 shares $134.11 thousand +19.7%0.8%1.1 $0.22 3/15/2022502,600 shares $136.20 thousand -9.4%0.9%2.1 $0.27 2/28/2022554,700 shares $179.33 thousand -2.6%1.0%2.4 $0.32 2/15/2022569,600 shares $214.74 thousand +11.0%1.1%2.4 $0.38 1/31/2022513,200 shares $182.19 thousand +0.1%1.0%2 $0.36 1/15/2022512,800 shares $215.38 thousand -28.9%0.9%1.9 $0.42 12/31/2021721,000 shares $295.61 thousand +18.3%1.3%2.8 $0.41 12/15/2021609,500 shares $329.74 thousand -3.7%1.1%2.6 $0.54 11/30/2021633,200 shares $413.23 thousand -55.1%1.2%2.4 $0.65 11/15/20211,410,000 shares $1.09 million -4.7%2.6%4.5 $0.78 10/29/20211,480,000 shares $1.10 million +16.5%2.7%4.5 $0.74 10/15/20211,270,000 shares $1.06 million -2.3%2.3%3.4 $0.83 9/30/20211,300,000 shares $1.20 million -11.0%2.4%3.2 $0.92 9/15/20211,460,000 shares $1.32 million -15.1%2.7%2.3 $0.91The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 8/31/20211,720,000 shares $1.57 million -10.9%3.2%2.3 $0.91 8/13/20211,930,000 shares $1.69 million -2.0%3.6%0.7 $0.88 7/30/20211,970,000 shares $1.79 million -14.7%3.6%0.7 $0.91 7/15/20212,310,000 shares $2.24 million -4.9%4.4%0.8 $0.97 6/30/20212,430,000 shares $2.77 million -46.1%4.6%0.8 $1.14 6/15/20214,510,000 shares $5.01 million +18.7%8.6%1.5 $1.11 5/28/20213,800,000 shares $3.91 million +36.2%7.3%1.1 $1.03 5/14/20212,790,000 shares $2.70 million -0.4%N/A1.4 $0.97 4/30/20212,800,000 shares $3.44 million +17.2%N/A1.4 $1.23 4/15/20212,390,000 shares $2.92 million -2.5%N/A1.2 $1.22 3/31/20212,450,000 shares $3.11 million +41.6%N/A1.4 $1.27 3/15/20211,730,000 shares $2.66 million +125.5%N/A1.2 $1.54 2/26/2021767,300 shares $1.94 million -0.9%N/A1.1 $2.53 2/12/2021774,300 shares $2.18 million -23.3%N/A2.5 $2.82 1/29/20211,010,000 shares $2.00 million +10.3%N/A3.5 $1.98 1/15/2021916,100 shares $2.00 million -7.9%N/A3.4 $2.18 12/31/2020994,300 shares $1.93 million +0.3%N/A3.6 $1.94 12/15/2020991,100 shares $1.84 million -1.9%N/A2.4 $1.86 11/30/20201,010,000 shares $1.94 million -2.9%N/A2 $1.92 11/15/20201,040,000 shares $2.14 million No ChangeN/A1.9 $2.06 10/30/20201,040,000 shares $1.67 million -21.8%N/A1.7 $1.61 10/15/20201,330,000 shares $2.65 million -17.4%N/A2.1 $1.99 9/30/20201,610,000 shares $4.04 million +15.8%N/A2.4 $2.51 9/15/20201,390,000 shares $2.95 million -10.3%N/A1.7 $2.12 8/31/20201,550,000 shares $3.32 million -13.9%N/A1.7 $2.14 8/14/20201,800,000 shares $3.37 million -11.3%N/A1.7 $1.87 7/31/20202,030,000 shares $3.49 million -21.6%N/A2 $1.72 7/15/20202,590,000 shares $4.71 million -8.5%N/A2.6 $1.82 6/30/20202,830,000 shares $6.28 million +56.4%15.4%3.1 $2.22 6/15/20201,810,000 shares $3.55 million +195.8%7.0%2.8 $1.96 SLNO Short Interest - Frequently Asked Questions What is Soleno Therapeutics' current short interest? Short interest is the volume of Soleno Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 4,150,000 shares of SLNO short. 9.95% of Soleno Therapeutics' shares are currently sold short. Learn More on Soleno Therapeutics' current short interest. What is a good short interest ratio for Soleno Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLNO shares currently have a short interest ratio of 3.0. Learn More on Soleno Therapeutics's short interest ratio. Which institutional investors are shorting Soleno Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Soleno Therapeutics: Jane Street Group LLC, Exome Asset Management LLC, Millennium Management LLC, ADAR1 Capital Management LLC, Nantahala Capital Management LLC, Caption Management LLC, Nomura Holdings Inc., HAP Trading LLC, Walleye Capital LLC, Persistent Asset Partners Ltd, and Jefferies Financial Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Soleno Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.95% of Soleno Therapeutics' floating shares are currently sold short. Is Soleno Therapeutics' short interest increasing or decreasing? Soleno Therapeutics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 4,150,000 shares, a decrease of 0.2% from the previous total of 4,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Soleno Therapeutics' float size? Soleno Therapeutics currently has issued a total of 50,394,000 shares. Some of Soleno Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Soleno Therapeutics currently has a public float of 41,690,000 shares. How does Soleno Therapeutics' short interest compare to its competitors? 9.95% of Soleno Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Soleno Therapeutics: Smith & Nephew plc (0.43%), Solventum Co. (3.33%), Penumbra, Inc. (4.13%), Stevanato Group S.p.A. (5.46%), Glaukos Co. (6.49%), TransMedics Group, Inc. (25.95%), iRhythm Technologies, Inc. (8.65%), Inari Medical, Inc. (4.24%), Bausch + Lomb Co. (7.03%), Inspire Medical Systems, Inc. (11.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Soleno Therapeutics stock? Short selling SLNO is an investing strategy that aims to generate trading profit from Soleno Therapeutics as its price is falling. SLNO shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Soleno Therapeutics? A short squeeze for Soleno Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLNO, which in turn drives the price of the stock up even further. How often is Soleno Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLNO, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies SNN Short Interest Data SOLV Short Interest Data PEN Short Interest Data STVN Short Interest Data GKOS Short Interest Data TMDX Short Interest Data IRTC Short Interest Data NARI Short Interest Data BLCO Short Interest Data INSP Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLNO) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
